Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other 2

Conditions

Obesity 2Polycystic Ovary Syndrome 1Metabolic Syndrome 1Inflammation 1Hyperandrogenism 1Dyslipidemias 1

Interventions

Exercise 24Metformin 19Tirzepatide 9Resistance Training 8Nutrition Assessment 8Methods 8Diet Therapy 8Diet 8Counseling 7Surveys and Questionnaires 6semaglutide 5Liraglutide 5Exenatide 5Early Intervention, Educational 5Diet, Mediterranean 5Caloric Restriction 5Blood Specimen Collection 5Educational Status 4Bariatric Surgery 4Vitamin D 3Sugars 3Standard of Care 3Naltrexone 3Letrozole 3Docosahexaenoic Acids 3Dexamethasone 3Bupropion 3exemestane 2bupropion hydrochloride, naltrexone hydrochoride drug combination 2Yoga 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Obesity × Topiramate × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

NCT04453306 2020-07-01

Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome

Hospital de Clinicas de Porto Alegre

Phase 4 Unknown
80 enrolled
Other

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡